Page last updated: 2024-10-25

dantrolene and Cryptogenic Infantile Spasms

dantrolene has been researched along with Cryptogenic Infantile Spasms in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molnar, GE1
Evangelista, LA1
Kathirithamby, R1
GarcĂ­a-Castro, JM1

Trials

1 trial available for dantrolene and Cryptogenic Infantile Spasms

ArticleYear
Dantrolene sodium: an effective therapeutic agent for the treatment of spasticity in children.
    Boletin de la Asociacion Medica de Puerto Rico, 1977, Volume: 69, Issue:8

    Topics: Capsules; Child; Child, Preschool; Clinical Trials as Topic; Dantrolene; Drug Evaluation; Humans; Hy

1977

Other Studies

1 other study available for dantrolene and Cryptogenic Infantile Spasms

ArticleYear
Dantrolene sodium in spasticity. Long-term administration in children.
    New York state journal of medicine, 1978, Volume: 78, Issue:8

    Topics: Child; Child, Preschool; Dantrolene; Drug Evaluation; Female; Humans; Hydantoins; Long-Term Care; Ma

1978